Total Payments
$515.74
2024 Payments
$136.68
Companies
8
Transactions
38
Medicare Patients
6,425
Medicare Billing
$526,514
Payment Breakdown by Category
Food & Beverage$496.34 (96.2%)
Gifts$19.40 (3.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $496.34 | 37 | 96.2% |
| Gift | $19.40 | 1 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $188.12 | 17 | $0 (2021) |
| ABBVIE INC. | $160.19 | 11 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $45.75 | 2 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $38.44 | 3 | $0 (2018) |
| Aerie Pharmaceuticals, Inc. | $30.38 | 2 | $0 (2021) |
| Valeant Pharmaceuticals North America LLC | $22.15 | 1 | $0 (2017) |
| Carl Zeiss Meditec AG | $19.40 | 1 | $0 (2020) |
| Omeros Corporation | $11.31 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $136.68 | 10 | ABBVIE INC. ($136.68) |
| 2023 | $23.51 | 1 | AbbVie Inc. ($23.51) |
| 2021 | $25.31 | 2 | Aerie Pharmaceuticals, Inc. ($13.86) |
| 2020 | $148.33 | 14 | Allergan, Inc. ($128.93) |
| 2019 | $70.03 | 4 | Allergan Inc. ($29.54) |
| 2018 | $34.43 | 2 | Bausch & Lomb, a division of Bausch Health US, LLC ($21.78) |
| 2017 | $77.45 | 5 | Novartis Pharmaceuticals Corporation ($25.79) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $9.09 | General |
| Category: EYE CARE | ||||||
| 11/15/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: EYE CARE | ||||||
| 11/06/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: EYE CARE | ||||||
| 10/10/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $4.30 | General |
| Category: EYE CARE | ||||||
| 08/22/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: EYE CARE | ||||||
| 07/25/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: EYE CARE | ||||||
| 05/31/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: EYE CARE | ||||||
| 05/02/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: EYE CARE | ||||||
| 03/12/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: EYE CARE | ||||||
| 02/29/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $7.53 | General |
| Category: EYE CARE | ||||||
| 01/06/2023 | AbbVie Inc. | ALPHAGAN P (Drug), LUMIGAN | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: EYE CARE | ||||||
| 11/30/2021 | Aerie Pharmaceuticals, Inc. | rocklatan (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Glaucoma | ||||||
| 09/10/2021 | Allergan, Inc. | RESTASIS MULTIDOSE (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: DRY EYE | ||||||
| 12/22/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/16/2020 | Allergan, Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $7.48 | General |
| Category: DRY EYE | ||||||
| 12/03/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $4.65 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/20/2020 | Allergan, Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $5.33 | General |
| Category: DRY EYE | ||||||
| 11/18/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $7.78 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/13/2020 | Allergan, Inc. | COMBIGAN (Drug) | Food and Beverage | In-kind items and services | $7.39 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/05/2020 | Allergan, Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $4.67 | General |
| Category: DRY EYE | ||||||
| 10/08/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/27/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/21/2020 | Allergan, Inc. | COMBIGAN (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/02/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/05/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,588 | 1,783 | $303,141 | $128,658 |
| 2022 | 15 | 1,701 | 1,896 | $327,409 | $139,837 |
| 2021 | 15 | 1,660 | 1,821 | $319,386 | $136,076 |
| 2020 | 12 | 1,476 | 1,637 | $306,006 | $121,943 |
Total Patients
6,425
Total Services
7,137
Medicare Billing
$526,514
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 706 | 708 | $134,520 | $59,479 | 44.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 134 | 244 | $39,040 | $21,129 | 54.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 215 | 270 | $29,700 | $16,990 | 57.2% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 18 | 20 | $23,880 | $8,698 | 36.4% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 155 | 173 | $23,050 | $7,887 | 34.2% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 55 | 55 | $12,375 | $4,631 | 37.4% |
| 92133 | Imaging of optic nerve | Office | 2023 | 136 | 140 | $19,560 | $3,542 | 18.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,640 | $1,483 | 56.2% |
| 92134 | Imaging of retina | Office | 2023 | 49 | 51 | $7,344 | $1,453 | 19.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 13 | 13 | $1,690 | $835.02 | 49.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 18 | $1,170 | $744.57 | 63.6% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 18 | 20 | $2,640 | $726.87 | 27.5% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 29 | 29 | $1,189 | $527.15 | 44.3% |
| 92250 | Photography of the retina | Office | 2023 | 16 | 16 | $3,968 | $410.79 | 10.4% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 15 | 15 | $375.00 | $122.72 | 32.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 700 | 702 | $133,380 | $59,148 | 44.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 143 | 217 | $34,720 | $19,822 | 57.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 240 | 299 | $32,941 | $18,698 | 56.8% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 23 | 30 | $35,820 | $12,780 | 35.7% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 152 | 174 | $23,272 | $8,162 | 35.1% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 58 | 58 | $13,050 | $6,105 | 46.8% |
| 92133 | Imaging of optic nerve | Office | 2022 | 155 | 156 | $21,840 | $4,021 | 18.4% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 11 | 12 | $5,892 | $3,329 | 56.5% |
| 92134 | Imaging of retina | Office | 2022 | 66 | 75 | $10,762 | $2,343 | 21.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 49 | 58 | $3,770 | $2,071 | 54.9% |
About Dr. Peter Brasch, MD
Dr. Peter Brasch, MD is a Ophthalmology healthcare provider based in Smithfield, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1023009404.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Brasch, MD has received a total of $515.74 in payments from pharmaceutical and medical device companies, with $136.68 received in 2024. These payments were reported across 38 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($496.34).
As a Medicare-enrolled provider, Brasch has provided services to 6,425 Medicare beneficiaries, totaling 7,137 services with total Medicare billing of $526,514. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Smithfield, RI
- Active Since 11/03/2005
- Last Updated 03/05/2015
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1023009404
Products in Payments
- LUMIGAN (Drug) $221.20
- COMBIGAN (Drug) $56.47
- RESTASIS (Drug) $35.68
- LOTEMAX SM (Drug) $23.97
- ALPHAGAN P (Drug) $23.51
- LOTEMAX GEL (Drug) $22.15
- BESIVANCE (Drug) $21.78
- None Specified (Medical Supply) $19.40
- Rhopressa (Drug) $16.52
- SIMBRINZA (Biological) $15.38
- rocklatan (Drug) $13.86
- TRAVATAN Z (Drug) $12.65
- RESTASIS MULTIDOSE (Drug) $11.45
- Omidria (Drug) $11.31
- PAZEO (Drug) $10.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.